Abstract
Bladder cancer is a common disease that causes significant morbidity and mortality in the United States. Early detection and routine surveillance are recommended in the management of this chronic and recurrent disease. Cystoscopic examination has been used for detection and follow-up; however, it is costly and is associated with patient discomfort. With advances in molecular biology and biochemistry, many diagnostic assays have been developed to supplement cystoscopy. The mechanisms and variable results of these assays are described. In addition, the economic and social implications of bladder cancer detection and surveillance are discussed. Copyright (C) 2000 Elsevier Science Inc.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 87-92 |
| Number of pages | 6 |
| Journal | Urologic Oncology: Seminars and Original Investigations |
| Volume | 5 |
| Issue number | 3 |
| DOIs | |
| State | Published - Apr 5 2000 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bladder neoplasms
- Transitional cell
- Tumor markers
ASJC Scopus subject areas
- Oncology
- Urology
Fingerprint
Dive into the research topics of 'The use of molecular diagnostics in bladder cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS